December 17, 2024
When asked about her 3 wishes for the future of obesity care, Donna Ryan, MD, told Patient Care that she had just one: access.
December 17, 2024
Your daily dose of the clinical news you may have missed.
December 16, 2024
Nemolizumab is the first approved monoclonal antibody that targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives disease mechanism in atopic dermatitis.
December 16, 2024
Find details on US colorectal cancer screening rates, dietary interventions for people with IBS, and research on the primary drivers of cost of IBD care.
December 16, 2024
Your daily dose of the clinical news you may have missed.
December 16, 2024
The future of obesity medicine is filled with promise as GLP-1 RAs and other peptides continue to demonstrate pluripotency in metabolic disease.
December 13, 2024
Intra-Cellular Therapies submitted an sNDA to the FDA for lumateperone for the treatment of MDD in adults as as adjunctive therapy to antidepressants.
December 13, 2024
Your daily dose of the clinical news you may have missed.
December 12, 2024
Donna Ryan, MD, highlights exciting advancements in weight loss and metabolic treatments, particularly involving GLP-1 RAs and related therapies.
December 12, 2024
Your daily dose of the clinical news you may have missed.